83 patients scheduled to undergo total hip arthroplasty were randomized to oral or intravenous tranexamic acid. The purpose of this study was to compare hemoglobin drop and total blood loss between groups to determine if these to methods of administration were equivalent. Results demonstrated equivalent hemoglobin drop and volume of total blood loss between the two groups. Transfusion was needed in 3 patients who received oral TXA and 1 patient who received intravenous TXA.
Unlock the full article
Get unlimited access to OrthoEvidence with a free trial
Start TrialCritical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or continue reading this full article
Register Now
Subscribe to "The Pulse"
Evidence-Based Orthopaedics direct to your inbox.
